| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.928 | 0.003 | 0.928 | Aldehyde oxidase inhibitor | 0.293 0.068 CID_154699598 | ||
| 0.871 | 0.004 | 0.871 | Caspase 9 stimulant | 0.855 0.005 CID_154699598 | ||
| 0.803 | 0.003 | 0.874 | Histamine release inhibitor | 0.874 0.003 CID_154699598 | CID_154699598 | |
| 0.749 | 0.002 | 0.749 | GABA C receptor rho-3 antagonist | 0.249 0.155 CID_154699598 | ||
| 0.73 | 0.003 | 0.73 | Peroxidase inhibitor | 0.153 0.076 CID_154699598 | ||
| 0.701 | 0.005 | 0.762 | Free radical scavenger | 0.762 0.004 CID_154699598 | CID_154699598 | |
| 0.698 | 0.009 | 0.698 | Aryl hydrocarbon receptor agonist | 0.222 0.091 CID_154699598 | ||
| 0.716 | 0.028 | 0.759 | Apoptosis agonist | 0.759 0.022 CID_154699598 | CID_154699598 | |
| 0.681 | 0.006 | 0.807 | Antioxidant | 0.807 0.004 CID_154699598 | CID_154699598 | |
| 0.682 | 0.008 | 0.682 | 12-Lipoxygenase inhibitor | |||
| 0.677 | 0.005 | 0.794 | 5 Hydroxytryptamine release inhibitor | 0.794 0.003 CID_154699598 | CID_154699598 | |
| 0.673 | 0.015 | 0.673 | 15-Lipoxygenase inhibitor | |||
| 0.639 | 0.003 | 0.639 | Cystathionine beta-synthase inhibitor | 0.474 0.004 CID_154699598 | ||
| 0.632 | 0.007 | 0.632 | Amyloid beta aggregation inhibitor | 0.378 0.028 CID_154699598 | ||
| 0.587 | 0.011 | 0.587 | Caspase 3 stimulant | 0.477 0.024 CID_154699598 | ||
| 0.581 | 0.008 | 0.581 | Superoxide dismutase inhibitor | |||
| 0.55 | 0.006 | 0.55 | MAO inhibitor | |||
| 0.542 | 0.004 | 0.542 | Aldehyde dehydrogenase inhibitor | 0.456 0.005 CID_154699598 | ||
| 0.542 | 0.004 | 0.542 | Breast cancer-resistant protein inhibitor | |||
| 0.53 | 0.005 | 0.53 | MAO A inhibitor | |||
| 0.526 | 0.002 | 0.526 | Creatine kinase inhibitor | 0.16 0.02 CID_154699598 | ||
| 0.533 | 0.015 | 0.533 | Lipoxygenase inhibitor | |||
| 0.552 | 0.037 | 0.796 | Transcription factor NF kappa B inhibitor | 0.796 0.013 CID_154699598 | CID_154699598 | |
| 0.531 | 0.018 | 0.531 | Calcium channel L-type activator | 0.335 0.129 CID_154699598 | ||
| 0.563 | 0.063 | 0.742 | Alpha-glucosidase inhibitor | 0.742 0.027 CID_154699598 | CID_154699598 | |
| 0.51 | 0.014 | 0.51 | Hypoxia-inducible factor 1 alpha inhibitor | 0.488 0.016 CID_154699598 | ||
| 0.51 | 0.026 | 0.51 | 5 Hydroxytryptamine release stimulant | 0.425 0.041 CID_154699598 | ||
| 0.487 | 0.007 | 0.679 | Melanin inhibitor | 0.679 0.003 CID_154699598 | CID_154699598 | |
| 0.482 | 0.01 | 0.482 | Pyruvate kinase inhibitor | 0.145 0.119 CID_154699598 | ||
| 0.47 | 0.003 | 0.47 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.127 0.026 CID_154699598 | ||
| 0.482 | 0.018 | 0.719 | Vasodilator, coronary | 0.719 0.004 CID_154699598 | CID_154699598 | |
| 0.467 | 0.004 | 0.467 | NADPH oxidase inhibitor | 0.362 0.006 CID_154699598 | ||
| 0.465 | 0.011 | 0.465 | P-glycoprotein inhibitor | 0.317 0.026 CID_154699598 | ||
| 0.495 | 0.043 | 0.495 | Prostaglandin dehydrogenase inhibitor | |||
| 0.454 | 0.007 | 0.454 | 5 Hydroxytryptamine uptake stimulant | 0.204 0.144 CID_154699598 | ||
| 0.449 | 0.003 | 0.449 | GABA C receptor rho-2 antagonist | 0.123 0.12 CID_154699598 | ||
| 0.454 | 0.009 | 0.678 | Monophenol monooxygenase inhibitor | 0.678 0.004 CID_154699598 | CID_154699598 | |
| 0.453 | 0.009 | 0.453 | Dual specificity phosphatase inhibitor | |||
| 0.447 | 0.006 | 0.447 | MAO B inhibitor | |||
| 0.443 | 0.008 | 0.456 | Topoisomerase II inhibitor | 0.456 0.008 CID_154699598 | CID_154699598 | |
| 0.436 | 0.005 | 0.436 | Acetylcholinesterase inhibitor | 0.113 0.085 CID_154699598 | ||
| 0.435 | 0.005 | 0.435 | Interleukin 4 antagonist | 0.253 0.013 CID_154699598 | ||
| 0.511 | 0.083 | 0.826 | Antiinflammatory | 0.826 0.012 CID_154699598 | CID_154699598 | |
| 0.45 | 0.031 | 0.582 | Spasmolytic | 0.582 0.015 CID_154699598 | CID_154699598 | |
| 0.426 | 0.006 | 0.426 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.315 0.019 CID_154699598 | ||
| 0.415 | 0.004 | 0.562 | Xanthine oxidase inhibitor | 0.562 0.003 CID_154699598 | CID_154699598 | |
| 0.421 | 0.016 | 0.421 | RNA-directed DNA polymerase inhibitor | 0.321 0.028 CID_154699598 | ||
| 0.428 | 0.025 | 0.494 | Antiamyloidogenic | 0.494 0.016 CID_154699598 | CID_154699598 | |
| 0.411 | 0.009 | 0.686 | Amylase inhibitor | 0.686 0.003 CID_154699598 | CID_154699598 | |
| 0.398 | 0.004 | 0.398 | Carbonic anhydrase III inhibitor | 0.226 0.012 CID_154699598 | ||
| 0.403 | 0.013 | 0.403 | Dual specificity phosphatase 3 inhibitor | |||
| 0.411 | 0.024 | 0.582 | Nitric oxide antagonist | 0.582 0.011 CID_154699598 | CID_154699598 | |
| 0.418 | 0.033 | 0.594 | Apoptosis antagonist | 0.594 0.01 CID_154699598 | CID_154699598 | |
| 0.389 | 0.005 | 0.389 | Topoisomerase II alpha inhibitor | 0.365 0.005 CID_154699598 | ||
| 0.41 | 0.026 | 0.735 | Hypoglycemic | 0.735 0.005 CID_154699598 | CID_154699598 | |
| 0.407 | 0.027 | 0.407 | DNA damaging | 0.402 0.028 CID_154699598 | ||
| 0.432 | 0.063 | 0.687 | Antibacterial | 0.687 0.01 CID_154699598 | CID_154699598 | |
| 0.37 | 0.004 | 0.37 | Estrogen receptor beta antagonist | |||
| 0.389 | 0.025 | 0.467 | Vasodilator | 0.467 0.014 CID_154699598 | CID_154699598 | |
| 0.371 | 0.01 | 0.446 | NOS3 expression enhancer | 0.446 0.006 CID_154699598 | CID_154699598 | |
| 0.383 | 0.023 | 0.383 | Transcription factor STAT inhibitor | |||
| 0.371 | 0.012 | 0.371 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.361 | 0.005 | 0.361 | Succinate dehydrogenase inhibitor | 0.175 0.074 CID_154699598 | ||
| 0.361 | 0.013 | 0.361 | Cholinergic | |||
| 0.352 | 0.005 | 0.352 | Estrogen antagonist | 0.124 0.048 CID_154699598 | ||
| 0.355 | 0.008 | 0.355 | Chelator | 0.103 0.074 CID_154699598 | ||
| 0.35 | 0.005 | 0.35 | Carbonic anhydrase VI inhibitor | 0.165 0.018 CID_154699598 | ||
| 0.347 | 0.005 | 0.347 | Carbonic anhydrase XV inhibitor | |||
| 0.341 | 0.008 | 0.341 | 5-Lipoxygenase inhibitor | |||
| 0.341 | 0.008 | 0.341 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.342 | 0.014 | 0.41 | Lipid peroxidase inhibitor | 0.41 0.009 CID_154699598 | CID_154699598 | |
| 0.371 | 0.045 | 0.371 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.342 | 0.02 | 0.608 | Hepatoprotectant | 0.608 0.004 CID_154699598 | CID_154699598 | |
| 0.326 | 0.005 | 0.326 | Estrogen receptor alpha antagonist | |||
| 0.325 | 0.005 | 0.685 | Beta glucuronidase inhibitor | 0.685 0.002 CID_154699598 | CID_154699598 | |
| 0.352 | 0.033 | 0.352 | Insulysin inhibitor | |||
| 0.34 | 0.022 | 0.512 | Platelet adhesion inhibitor | 0.512 0.005 CID_154699598 | CID_154699598 | |
| 0.329 | 0.012 | 0.329 | Neurotrophic factor enhancer | 0.305 0.017 CID_154699598 | ||
| 0.325 | 0.009 | 0.325 | Alkaline phosphatase inhibitor | 0.307 0.011 CID_154699598 | ||
| 0.314 | 0.004 | 0.314 | Multidrug resistance-associated protein 1 inhibitor | 0.246 0.005 CID_154699598 | ||
| 0.318 | 0.008 | 0.318 | Nitric-oxide synthase stimulant | 0.307 0.01 CID_154699598 | ||
| 0.365 | 0.057 | 0.365 | Streptokinase A inhibitor | |||
| 0.323 | 0.017 | 0.323 | Tubulin antagonist | |||
| 0.32 | 0.016 | 0.32 | Protein-tyrosine phosphatase inhibitor | 0.24 0.034 CID_154699598 | ||
| 0.325 | 0.027 | 0.325 | MAP kinase kinase 2 inhibitor | |||
| 0.301 | 0.004 | 0.301 | GABA C receptor antagonist | |||
| 0.299 | 0.006 | 0.299 | Histidine decarboxylase inhibitor | |||
| 0.331 | 0.04 | 0.331 | Transcription factor STAT3 inhibitor | |||
| 0.287 | 0.004 | 0.287 | GABA C receptor rho-1 antagonist | |||
| 0.294 | 0.011 | 0.294 | Butyrylcholinesterase inhibitor | |||
| 0.283 | 0.007 | 0.283 | Telomerase inhibitor | 0.064 0.06 CID_154699598 | ||
| 0.278 | 0.005 | 0.278 | Electron transport complex I inhibitor | 0.107 0.067 CID_154699598 | ||
| 0.29 | 0.021 | 0.441 | Interferon gamma antagonist | 0.441 0.009 CID_154699598 | CID_154699598 | |
| 0.273 | 0.007 | 0.296 | Carbonic anhydrase XIII inhibitor | 0.296 0.006 CID_154699598 | CID_154699598 | |
| 0.282 | 0.019 | 0.469 | Protein kinase stimulant | 0.469 0.005 CID_154699598 | CID_154699598 | |
| 0.267 | 0.005 | 0.267 | Aldose reductase inhibitor | 0.211 0.007 CID_154699598 | ||
| 0.266 | 0.006 | 0.266 | Uric acid excretion stimulant | 0.252 0.007 CID_154699598 | ||
| 0.307 | 0.048 | 0.307 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.261 | 0.003 | 0.261 | DOPA decarboxylase inhibitor | |||
| 0.326 | 0.068 | 0.326 | Calcium channel activator | |||
| 0.263 | 0.009 | 0.592 | Mediator release inhibitor | 0.592 0.004 CID_154699598 | CID_154699598 | |
| 0.284 | 0.032 | 0.555 | Non-steroidal antiinflammatory agent | 0.555 0.005 CID_154699598 | CID_154699598 | |
| 0.279 | 0.027 | 0.279 | Mcl-1 antagonist | |||
| 0.298 | 0.05 | 0.805 | Angiogenesis stimulant | 0.805 0.004 CID_154699598 | CID_154699598 | |
| 0.267 | 0.021 | 0.267 | Heat shock protein 90 alpha antagonist | |||
| 0.291 | 0.046 | 0.431 | Cyclic AMP phosphodiesterase inhibitor | 0.431 0.013 CID_154699598 | CID_154699598 | |
| 0.247 | 0.003 | 0.247 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.23 0.004 CID_154699598 | ||
| 0.279 | 0.035 | 0.381 | DNA methyltransferase I inhibitor | 0.381 0.01 CID_154699598 | CID_154699598 | |
| 0.255 | 0.015 | 0.255 | Protein kinase (CK2) alpha inhibitor | |||
| 0.251 | 0.012 | 0.263 | Mannose-6-phosphate isomerase inhibitor | 0.263 0.009 CID_154699598 | CID_154699598 | |
| 0.243 | 0.004 | 0.243 | DNA-dependent protein kinase inhibitor | |||
| 0.257 | 0.019 | 0.257 | Heat shock protein 90 antagonist | |||
| 0.241 | 0.005 | 0.241 | Macrophage migration inhibitory factor inhibitor | |||
| 0.281 | 0.047 | 0.281 | Gastrin inhibitor | 0.221 0.118 CID_154699598 | ||
| 0.256 | 0.022 | 0.442 | Alpha-N-acetylglucosaminidase inhibitor | 0.442 0.007 CID_154699598 | CID_154699598 | |
| 0.257 | 0.023 | 0.257 | Bone formation stimulant | 0.162 0.051 CID_154699598 | ||
| 0.261 | 0.029 | 0.261 | Amyloid beta precursor protein antagonist | |||
| 0.247 | 0.017 | 0.247 | Protein-tyrosine phosphatase 1B inhibitor | 0.219 0.024 CID_154699598 | ||
| 0.236 | 0.007 | 0.236 | HIV-1 integrase (3'-Processing) inhibitor | 0.102 0.025 CID_154699598 | ||
| 0.314 | 0.087 | 0.314 | Thyroid hormone antagonist | |||
| 0.226 | 0.003 | 0.226 | GABA B receptor antagonist | |||
| 0.256 | 0.034 | 0.256 | I kappa B kinase epsilon inhibitor | |||
| 0.229 | 0.007 | 0.229 | Aromatase inhibitor | |||
| 0.224 | 0.004 | 0.224 | Xanthine dehydrogenase inhibitor | 0.112 0.013 CID_154699598 | ||
| 0.237 | 0.017 | 0.389 | ATPase inhibitor | 0.389 0.004 CID_154699598 | CID_154699598 | |
| 0.239 | 0.019 | 0.336 | Topoisomerase I inhibitor | 0.336 0.008 CID_154699598 | CID_154699598 | |
| 0.227 | 0.011 | 0.227 | CF transmembrane conductance regulator agonist | 0.144 0.087 CID_154699598 | ||
| 0.223 | 0.007 | 0.223 | Papain-like protease (SARS coronavirus) inhibitor | 0.12 0.081 CID_154699598 | ||
| 0.272 | 0.062 | 0.272 | Dyrk kinase inhibitor | |||
| 0.216 | 0.007 | 0.445 | DNA repair enzyme inhibitor | 0.445 0.003 CID_154699598 | CID_154699598 | |
| 0.224 | 0.015 | 0.224 | Protein kinase (CK2) inhibitor | |||
| 0.217 | 0.01 | 0.274 | Photosensitizer | 0.274 0.005 CID_154699598 | CID_154699598 | |
| 0.253 | 0.047 | 0.377 | DNA methylase inhibitor | 0.377 0.013 CID_154699598 | CID_154699598 | |
| 0.264 | 0.058 | 0.425 | DNA synthesis inhibitor | 0.425 0.019 CID_154699598 | CID_154699598 | |
| 0.263 | 0.06 | 0.263 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.207 | 0.005 | 0.207 | Cyclin B3 inhibitor | |||
| 0.231 | 0.03 | 0.231 | Phospholipase C inhibitor | 0.189 0.052 CID_154699598 | ||
| 0.211 | 0.01 | 0.211 | Protein kinase C zeta inhibitor | |||
| 0.292 | 0.092 | 0.292 | Thyroid hormone beta antagonist | |||
| 0.216 | 0.016 | 0.412 | UDP-glucose 4-epimerase inhibitor | 0.412 0.005 CID_154699598 | CID_154699598 | |
| 0.208 | 0.009 | 0.208 | HIV-1 integrase (Strand Transfer) inhibitor | 0.089 0.027 CID_154699598 | ||
| 0.218 | 0.019 | 0.218 | Arachidonic acid antagonist | 0.161 0.075 CID_154699598 | ||
| 0.203 | 0.006 | 0.203 | CDC25A inhibitor | 0.082 0.041 CID_154699598 | ||
| 0.204 | 0.008 | 0.204 | Estrogen agonist | 0.104 0.016 CID_154699598 | ||
| 0.264 | 0.069 | 0.501 | Tumour necrosis factor alpha release inhibitor | 0.501 0.014 CID_154699598 | CID_154699598 | |
| 0.252 | 0.058 | 0.252 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.218 | 0.024 | 0.218 | Death-associated protein kinase 2 inhibitor | |||
| 0.201 | 0.007 | 0.201 | CYP2A6 inhibitor | |||
| 0.289 | 0.096 | 0.704 | Antithrombotic | 0.704 0.008 CID_154699598 | CID_154699598 | |
| 0.204 | 0.012 | 0.204 | Alcohol dehydrogenase inhibitor | 0.151 0.02 CID_154699598 | ||
| 0.21 | 0.019 | 0.21 | Toll-Like receptor 2 antagonist | |||
| 0.235 | 0.044 | 0.235 | Insulin sensitizer | 0.199 0.074 CID_154699598 | ||
| 0.197 | 0.007 | 0.199 | Heat shock protein 70 antagonist | 0.199 0.006 CID_154699598 | CID_154699598 | |
| 0.198 | 0.009 | 0.198 | Keratolytic | |||
| 0.217 | 0.028 | 0.384 | Insulin secretagoues | 0.384 0.007 CID_154699598 | CID_154699598 | |
| 0.195 | 0.006 | 0.195 | Alpha tubulin antagonist | |||
| 0.222 | 0.034 | 0.222 | Cyclooxygenase inhibitor | 0.136 0.082 CID_154699598 | ||
| 0.227 | 0.039 | 0.227 | Tumour necrosis factor antagonist | |||
| 0.198 | 0.011 | 0.198 | TRPA1 agonist | 0.146 0.034 CID_154699598 | ||
| 0.191 | 0.005 | 0.194 | Histone deacetylase SIRT1 stimulant | 0.194 0.005 CID_154699598 | CID_154699598 | |
| 0.191 | 0.005 | 0.194 | Histone deacetylase stimulant | 0.194 0.005 CID_154699598 | CID_154699598 | |
| 0.199 | 0.015 | 0.199 | Potassium channel (Ca-activated) activator | |||
| 0.188 | 0.007 | 0.188 | Alcohol oxidase inhibitor | |||
| 0.194 | 0.013 | 0.194 | Porphobilinogen synthase inhibitor | |||
| 0.184 | 0.004 | 0.184 | D-Ala-D-Ala ligase inhibitor | |||
| 0.183 | 0.005 | 0.183 | CD45 antagonist | |||
| 0.182 | 0.004 | 0.182 | Fatty acid synthase inhibitor | 0.084 0.017 CID_154699598 | ||
| 0.208 | 0.031 | 0.208 | Cyclooxygenase 1 inhibitor | 0.123 0.077 CID_154699598 | ||
| 0.328 | 0.15 | 0.328 | DNA polymerase beta inhibitor | |||
| 0.324 | 0.15 | 0.324 | DNA directed DNA polymerase inhibitor | |||
| 0.214 | 0.042 | 0.214 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.277 | 0.106 | 0.536 | Cholesterol antagonist | 0.536 0.027 CID_154699598 | CID_154699598 | |
| 0.178 | 0.007 | 0.178 | Myeloperoxidase inhibitor | |||
| 0.235 | 0.064 | 0.235 | Psychostimulant | 0.213 0.073 CID_154699598 | ||
| 0.172 | 0.005 | 0.172 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.189 | 0.022 | 0.189 | GABA C receptor agonist | |||
| 0.272 | 0.105 | 0.272 | Sodium/bile acid cotransporter inhibitor | |||
| 0.172 | 0.005 | 0.172 | Estrogen receptor beta agonist | 0.068 0.016 CID_154699598 | ||
| 0.179 | 0.015 | 0.179 | Sphingomyelinase inhibitor | 0.132 0.033 CID_154699598 | ||
| 0.18 | 0.016 | 0.18 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.213 | 0.051 | 0.213 | Histone acetyltransferase inhibitor | |||
| 0.168 | 0.007 | 0.168 | Thioredoxin reductase inhibitor | 0.088 0.044 CID_154699598 | ||
| 0.166 | 0.004 | 0.166 | Aryl hydrocarbon receptor antagonist | |||
| 0.177 | 0.017 | 0.177 | Androgen antagonist | |||
| 0.189 | 0.03 | 0.318 | Alkylator | 0.318 0.012 CID_154699598 | CID_154699598 | |
| 0.182 | 0.024 | 0.182 | Adenylate cyclase stimulant | 0.135 0.091 CID_154699598 | ||
| 0.172 | 0.015 | 0.172 | Urease inhibitor | |||
| 0.195 | 0.038 | 0.335 | Hexokinase inhibitor | 0.335 0.008 CID_154699598 | CID_154699598 | |
| 0.27 | 0.114 | 0.27 | Vasodilator, peripheral | 0.264 0.117 CID_154699598 | ||
| 0.16 | 0.005 | 0.16 | Protease activated receptor antagonist | |||
| 0.181 | 0.027 | 0.412 | Cyclooxygenase 3 inhibitor | 0.412 0.004 CID_154699598 | CID_154699598 | |
| 0.204 | 0.049 | 0.204 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.167 | 0.013 | 0.169 | Thioredoxin inhibitor | 0.169 0.012 CID_154699598 | CID_154699598 | |
| 0.187 | 0.035 | 0.187 | Cyclooxygenase 2 inhibitor | 0.116 0.084 CID_154699598 | ||
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.162 0.021 CID_154699598 | ||
| 0.184 | 0.031 | 0.184 | Cholesterol synthesis inhibitor | 0.121 0.064 CID_154699598 | ||
| 0.167 | 0.016 | 0.167 | Prolactin inhibitor | |||
| 0.158 | 0.009 | 0.158 | Ornithine decarboxylase inhibitor | 0.127 0.021 CID_154699598 | ||
| 0.19 | 0.041 | 0.19 | Neurotensin receptor agonist | |||
| 0.175 | 0.03 | 0.175 | Antibacterial (Helicobacter pylori) | |||
| 0.153 | 0.009 | 0.153 | Carbonic anhydrase VB inhibitor | |||
| 0.16 | 0.017 | 0.16 | Transcription factor STAT6 inhibitor | |||
| 0.323 | 0.182 | 0.323 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.21 | 0.069 | 0.21 | Anesthetic general | 0.204 0.072 CID_154699598 | ||
| 0.161 | 0.021 | 0.376 | AMP-activated protein kinase stimulant | 0.376 0.004 CID_154699598 | CID_154699598 | |
| 0.301 | 0.161 | 0.812 | Cyclophilin D inhibitor | 0.812 0.006 CID_154699598 | CID_154699598 | |
| 0.143 | 0.003 | 0.143 | Dopamine D5 agonist | |||
| 0.153 | 0.014 | 0.153 | Carbonic anhydrase V inhibitor | |||
| 0.141 | 0.003 | 0.141 | Glutamate (mGluR7) antagonist | |||
| 0.156 | 0.018 | 0.335 | Triose-phosphate isomerase inhibitor | 0.335 0.004 CID_154699598 | CID_154699598 | |
| 0.148 | 0.012 | 0.148 | Beta tubulin antagonist | |||
| 0.147 | 0.014 | 0.147 | Glutamate decarboxylase inhibitor | |||
| 0.236 | 0.102 | 0.518 | Immunostimulant | 0.518 0.027 CID_154699598 | CID_154699598 | |
| 0.135 | 0.005 | 0.135 | Topoisomerase II beta inhibitor | 0.096 0.01 CID_154699598 | ||
| 0.157 | 0.029 | 0.166 | Mucolytic | 0.166 0.024 CID_154699598 | CID_154699598 | |
| 0.139 | 0.012 | 0.139 | Leukotriene antagonist | 0.104 0.02 CID_154699598 | ||
| 0.163 | 0.037 | 0.163 | Adenylate cyclase inhibitor | 0.108 0.077 CID_154699598 | ||
| 0.139 | 0.013 | 0.139 | Carbonic anhydrase VA inhibitor | |||
| 0.174 | 0.05 | 0.174 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.171 | 0.047 | 0.349 | Cell wall synthesis inhibitor | 0.349 0.008 CID_154699598 | CID_154699598 | |
| 0.143 | 0.019 | 0.276 | NADH dehydrogenase inhibitor | 0.276 0.007 CID_154699598 | CID_154699598 | |
| 0.136 | 0.015 | 0.136 | Interleukin 5 antagonist | 0.119 0.025 CID_154699598 | ||
| 0.141 | 0.023 | 0.141 | Anabolic | |||
| 0.129 | 0.012 | 0.129 | HIV-1 integrase inhibitor | |||
| 0.16 | 0.044 | 0.16 | MAP kinase kinase 4 inhibitor | |||
| 0.154 | 0.038 | 0.178 | Beta amyloid protein antagonist | 0.178 0.025 CID_154699598 | CID_154699598 | |
| 0.127 | 0.014 | 0.127 | mTOR complex 2 inhibitor | |||
| 0.122 | 0.011 | 0.122 | Purinergic P2X1 antagonist | 0.063 0.039 CID_154699598 | ||
| 0.126 | 0.015 | 0.126 | Potassium channel large-conductance Ca-activated activator | |||
| 0.121 | 0.011 | 0.121 | CDC25B inhibitor | |||
| 0.115 | 0.007 | 0.115 | Heat shock protein 90 beta antagonist | |||
| 0.145 | 0.037 | 0.436 | Expectorant | 0.436 0.004 CID_154699598 | CID_154699598 | |
| 0.117 | 0.011 | 0.117 | Maillard reaction inhibitor | 0.047 0.046 CID_154699598 | ||
| 0.117 | 0.013 | 0.117 | GABA receptor antagonist | |||
| 0.165 | 0.062 | 0.165 | Phospholipase A2 inhibitor | 0.141 0.085 CID_154699598 | ||
| 0.135 | 0.034 | 0.293 | Antineoplastic antibiotic | 0.293 0.01 CID_154699598 | CID_154699598 | |
| 0.123 | 0.022 | 0.154 | Phosphodiesterase 6D inhibitor | 0.154 0.009 CID_154699598 | CID_154699598 | |
| 0.167 | 0.067 | 0.264 | Interleukin 6 antagonist | 0.264 0.02 CID_154699598 | CID_154699598 | |
| 0.104 | 0.005 | 0.104 | Transcription factor RelA inhibitor | |||
| 0.188 | 0.091 | 0.188 | Interleukin antagonist | |||
| 0.117 | 0.019 | 0.117 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.106 | 0.009 | 0.106 | Carbonic anhydrase VII inhibitor | 0.051 0.027 CID_154699598 | ||
| 0.136 | 0.044 | 0.136 | 5 Hydroxytryptamine 3A agonist | |||
| 0.129 | 0.037 | 0.129 | Adenylate kinase inhibitor | 0.106 0.059 CID_154699598 | ||
| 0.112 | 0.021 | 0.112 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.117 | 0.026 | 0.215 | Phosphofructokinase-1 inhibitor | 0.215 0.01 CID_154699598 | CID_154699598 | |
| 0.095 | 0.005 | 0.095 | Adenylate cyclase 1 inhibitor | |||
| 0.102 | 0.011 | 0.102 | MAP kinase kinase 7 inhibitor | |||
| 0.099 | 0.009 | 0.099 | Estrogen receptor alpha agonist | |||
| 0.12 | 0.03 | 0.12 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.115 | 0.025 | 0.115 | Glutathione S-transferase inhibitor | |||
| 0.098 | 0.009 | 0.098 | Potassium channel Kv1.3 blocker | |||
| 0.109 | 0.021 | 0.109 | Leukotriene synthesis inhibitor | |||
| 0.106 | 0.018 | 0.106 | Estrogen-related receptor beta agonist | |||
| 0.151 | 0.066 | 0.426 | Hemostatic | 0.426 0.006 CID_154699598 | CID_154699598 | |
| 0.135 | 0.049 | 0.135 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.138 | 0.056 | 0.156 | DNA polymerase I inhibitor | 0.156 0.046 CID_154699598 | CID_154699598 | |
| 0.095 | 0.013 | 0.095 | Glutamate (mGluR6) antagonist | |||
| 0.093 | 0.012 | 0.093 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.084 | 0.006 | 0.084 | Cholesterol esterase inhibitor | |||
| 0.084 | 0.006 | 0.084 | Leukotriene C antagonist | 0.054 0.047 CID_154699598 | ||
| 0.117 | 0.041 | 0.174 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.174 0.02 CID_154699598 | CID_154699598 | |
| 0.16 | 0.084 | 0.16 | Catenin beta inhibitor | |||
| 0.093 | 0.017 | 0.093 | Beta 3 adrenoreceptor antagonist | |||
| 0.115 | 0.04 | 0.115 | MAP kinase kinase 1 inhibitor | |||
| 0.082 | 0.008 | 0.082 | Ryanodine receptor antagonist | |||
| 0.079 | 0.005 | 0.079 | Sirtuin 2 inhibitor | |||
| 0.091 | 0.019 | 0.153 | Neuraminidase (influenza) inhibitor | 0.153 0.007 CID_154699598 | CID_154699598 | |
| 0.1 | 0.027 | 0.1 | Lipase inhibitor | |||
| 0.076 | 0.005 | 0.076 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.075 | 0.004 | 0.075 | Protein kinase (CK2) beta inhibitor | |||
| 0.148 | 0.079 | 0.291 | Diuretic | 0.291 0.024 CID_154699598 | CID_154699598 | |
| 0.074 | 0.004 | 0.074 | ATP citrate lysase inhibitor | |||
| 0.095 | 0.027 | 0.095 | Dopamine D1 antagonist | |||
| 0.088 | 0.02 | 0.129 | Neuraminidase inhibitor | 0.129 0.008 CID_154699598 | CID_154699598 | |
| 0.19 | 0.123 | 0.19 | Calpain inhibitor | |||
| 0.131 | 0.064 | 0.131 | Vanilloid 1 agonist | 0.122 0.082 CID_154699598 | ||
| 0.083 | 0.017 | 0.083 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.074 | 0.008 | 0.074 | Purinergic P2X4 antagonist | |||
| 0.098 | 0.032 | 0.098 | Glutamate dehydrogenase inhibitor | |||
| 0.085 | 0.02 | 0.085 | GABA A receptor antagonist | |||
| 0.122 | 0.056 | 0.19 | DNA intercalator | 0.19 0.029 CID_154699598 | CID_154699598 | |
| 0.08 | 0.015 | 0.105 | Leukotriene B4 antagonist | 0.105 0.009 CID_154699598 | CID_154699598 | |
| 0.229 | 0.164 | 0.229 | Calpain 2 inhibitor | |||
| 0.137 | 0.072 | 0.137 | Neurotrophic factor | 0.127 0.085 CID_154699598 | ||
| 0.069 | 0.005 | 0.069 | Dopamine autoreceptor agonist | |||
| 0.125 | 0.061 | 0.125 | Proteasome inhibitor | |||
| 0.115 | 0.053 | 0.115 | Alpha 2c adrenoreceptor antagonist | |||
| 0.086 | 0.024 | 0.086 | NMDA receptor glycine site agonist | |||
| 0.121 | 0.06 | 0.121 | Interleukin 8 antagonist | |||
| 0.065 | 0.004 | 0.065 | Estrogen-related receptor beta antagonist | |||
| 0.14 | 0.079 | 0.14 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.077 | 0.016 | 0.077 | Cyclin B2 inhibitor | |||
| 0.08 | 0.021 | 0.08 | Cyclin B1 inhibitor | |||
| 0.095 | 0.036 | 0.121 | Na+ K+ transporting ATPase inhibitor | 0.121 0.016 CID_154699598 | CID_154699598 | |
| 0.067 | 0.009 | 0.067 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.09 | 0.032 | 0.09 | Adenosine A3 receptor antagonist | |||
| 0.064 | 0.007 | 0.064 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.066 | 0.009 | 0.066 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.102 | 0.046 | 0.102 | Calcium antagonist | |||
| 0.072 | 0.016 | 0.072 | Dihydroorotate oxidase inhibitor | |||
| 0.118 | 0.063 | 0.16 | Microtubule formation inhibitor | 0.16 0.033 CID_154699598 | CID_154699598 | |
| 0.112 | 0.057 | 0.112 | Aminopeptidase B inhibitor | |||
| 0.058 | 0.005 | 0.058 | Vanilloid 3 antagonist | |||
| 0.244 | 0.191 | 0.244 | Transcription factor inhibitor | |||
| 0.063 | 0.01 | 0.081 | Neuraminidase (Influenza A) inhibitor | 0.081 0.005 CID_154699598 | CID_154699598 | |
| 0.091 | 0.038 | 0.127 | Interferon agonist | 0.127 0.015 CID_154699598 | CID_154699598 | |
| 0.059 | 0.006 | 0.059 | Leukotriene C4 antagonist | |||
| 0.071 | 0.02 | 0.118 | Carbonic anhydrase XIV inhibitor | 0.118 0.007 CID_154699598 | CID_154699598 | |
| 0.088 | 0.037 | 0.088 | GABA aminotransferase inhibitor | 0.082 0.044 CID_154699598 | ||
| 0.07 | 0.019 | 0.07 | Aconitate hydratase inhibitor | |||
| 0.108 | 0.057 | 0.179 | Toll-Like receptor 4 antagonist | 0.179 0.01 CID_154699598 | CID_154699598 | |
| 0.094 | 0.043 | 0.094 | Inducible nitric-oxide synthase inhibitor | |||
| 0.089 | 0.039 | 0.107 | T cell inhibitor | 0.107 0.019 CID_154699598 | CID_154699598 | |
| 0.077 | 0.026 | 0.143 | Carbonic anhydrase XII inhibitor | 0.143 0.013 CID_154699598 | CID_154699598 | |
| 0.076 | 0.026 | 0.076 | Androgen agonist | |||
| 0.111 | 0.061 | 0.111 | Ferrochelatase inhibitor | |||
| 0.129 | 0.08 | 0.129 | Cytokine production inhibitor | |||
| 0.084 | 0.035 | 0.084 | Dopamine agonist | |||
| 0.073 | 0.025 | 0.073 | Cyclin D1 inhibitor | |||
| 0.058 | 0.011 | 0.058 | DNA gyrase subunit A inhibitor | |||
| 0.083 | 0.036 | 0.083 | GABA B receptor agonist | |||
| 0.062 | 0.017 | 0.091 | Glucose-6-phosphate isomerase inhibitor | 0.091 0.006 CID_154699598 | CID_154699598 | |
| 0.068 | 0.023 | 0.068 | Cyclin B inhibitor | |||
| 0.07 | 0.026 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.081 0.02 CID_154699598 | CID_154699598 | |
| 0.07 | 0.026 | 0.07 | Heme oxygenase stimulant | |||
| 0.079 | 0.036 | 0.079 | Sirtuin 1 inhibitor | |||
| 0.11 | 0.066 | 0.11 | Alpha 2b adrenoreceptor antagonist | |||
| 0.088 | 0.045 | 0.088 | Caspase 7 inhibitor | |||
| 0.075 | 0.032 | 0.075 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.068 | 0.026 | 0.068 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.055 | 0.013 | 0.092 | Arginase inhibitor | 0.092 0.004 CID_154699598 | CID_154699598 | |
| 0.095 | 0.054 | 0.095 | Potassium channel activator | |||
| 0.068 | 0.027 | 0.068 | Sphingosine kinase inhibitor | |||
| 0.069 | 0.029 | 0.069 | Protein kinase C eta inhibitor | |||
| 0.073 | 0.033 | 0.073 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.099 | 0.061 | 0.099 | Glutamate (mGluR7) agonist | |||
| 0.124 | 0.086 | 0.124 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.08 | 0.042 | 0.08 | Phosphodiesterase VI inhibitor | 0.077 0.046 CID_154699598 | ||
| 0.132 | 0.095 | 0.132 | Pregnane X receptor agonist | |||
| 0.068 | 0.031 | 0.068 | Argininosuccinate synthase inhibitor | |||
| 0.216 | 0.18 | 0.511 | Immunosuppressant | 0.511 0.03 CID_154699598 | CID_154699598 | |
| 0.08 | 0.044 | 0.08 | Cathepsin G inhibitor | |||
| 0.05 | 0.014 | 0.05 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.077 | 0.042 | 0.077 | Glycine receptor agonist | 0.067 0.061 CID_154699598 | ||
| 0.058 | 0.024 | 0.058 | CXC chemokine 1 receptor antagonist | |||
| 0.107 | 0.072 | 0.108 | Acetylcholine release stimulant | 0.108 0.069 CID_154699598 | CID_154699598 | |
| 0.04 | 0.006 | 0.04 | Glutamate (mGluR1a) agonist | |||
| 0.084 | 0.051 | 0.115 | Glycine receptor antagonist | 0.115 0.021 CID_154699598 | CID_154699598 | |
| 0.055 | 0.022 | 0.055 | Dopamine D5 antagonist | |||
| 0.047 | 0.014 | 0.047 | Glutamate (mGluR8) agonist | |||
| 0.109 | 0.077 | 0.109 | Caspase 3 inhibitor | |||
| 0.058 | 0.026 | 0.219 | Heparanase inhibitor | 0.219 0.002 CID_154699598 | CID_154699598 | |
| 0.04 | 0.009 | 0.04 | Estrone sulfatase inhibitor | |||
| 0.06 | 0.03 | 0.06 | Pregnane X receptor antagonist | |||
| 0.174 | 0.145 | 0.316 | Interleukin agonist | 0.316 0.041 CID_154699598 | CID_154699598 | |
| 0.15 | 0.121 | 0.15 | Antimitotic | |||
| 0.076 | 0.048 | 0.076 | Vanilloid 4 agonist | |||
| 0.045 | 0.017 | 0.045 | Retinoid X alpha receptor agonist | |||
| 0.041 | 0.013 | 0.041 | Catechol O-methyltransferase inhibitor | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR group III) antagonist | |||
| 0.067 | 0.039 | 0.067 | NMDA receptor agonist | |||
| 0.046 | 0.018 | 0.046 | Retinoic acid alpha receptor agonist | |||
| 0.093 | 0.066 | 0.093 | Bile acid receptor antagonist | |||
| 0.054 | 0.027 | 0.054 | Squalene epoxidase inhibitor | |||
| 0.054 | 0.028 | 0.054 | Potassium channel (Inward rectifier) activator | |||
| 0.052 | 0.025 | 0.07 | Cytokine production stimulant | 0.07 0.007 CID_154699598 | CID_154699598 | |
| 0.045 | 0.02 | 0.045 | Progesterone antagonist | |||
| 0.124 | 0.098 | 0.156 | CC chemokine 6 receptor antagonist | 0.156 0.016 CID_154699598 | CID_154699598 | |
| 0.067 | 0.042 | 0.067 | Beta adrenoreceptor antagonist | |||
| 0.063 | 0.038 | 0.063 | Adenosine A1 receptor antagonist | |||
| 0.092 | 0.068 | 0.092 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.051 | 0.027 | 0.051 | Potassium channel (ATP-sensitive) activator | |||
| 0.048 | 0.024 | 0.048 | Cathepsin L2 inhibitor | |||
| 0.033 | 0.011 | 0.122 | Sodium/glucose cotransporter 2 inhibitor | 0.122 0.002 CID_154699598 | CID_154699598 | |
| 0.051 | 0.028 | 0.051 | Aldosterone antagonist | |||
| 0.036 | 0.014 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.065 | 0.043 | 0.089 | Interferon inducer | 0.089 0.018 CID_154699598 | CID_154699598 | |
| 0.13 | 0.108 | 0.13 | MAP kinase 3 inhibitor | |||
| 0.108 | 0.086 | 0.108 | MAP kinase kinase inhibitor | |||
| 0.029 | 0.008 | 0.029 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.044 | 0.025 | 0.044 | Liver X receptor alpha agonist | |||
| 0.025 | 0.005 | 0.036 | Antibiotic Anthracycline-like | 0.036 0.003 CID_154699598 | CID_154699598 | |
| 0.041 | 0.022 | 0.041 | Retinoid X receptor antagonist | |||
| 0.06 | 0.041 | 0.06 | Biliverdin reductase inhibitor | |||
| 0.091 | 0.072 | 0.091 | Electrolyte absorption antagonist | |||
| 0.069 | 0.051 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.04 | 0.022 | 0.04 | Retinoid X receptor agonist | |||
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | |||
| 0.11 | 0.093 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.03 | 0.013 | 0.03 | Thyroid hormone agonist | |||
| 0.024 | 0.008 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.028 | 0.013 | 0.114 | Sodium/glucose cotransporter inhibitor | 0.114 0.002 CID_154699598 | CID_154699598 | |
| 0.037 | 0.023 | 0.037 | ATM kinase inhibitor | |||
| 0.08 | 0.065 | 0.08 | NMDA receptor antagonist | |||
| 0.027 | 0.013 | 0.027 | Glutamate (mGluR1) agonist | |||
| 0.026 | 0.012 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.023 0.014 CID_154699598 | ||
| 0.069 | 0.055 | 0.069 | Aminopeptidase I inhibitor | |||
| 0.088 | 0.076 | 0.121 | Interleukin 12 antagonist | 0.121 0.028 CID_154699598 | CID_154699598 | |
| 0.027 | 0.014 | 0.044 | Vanilloid 2 agonist | 0.044 0.004 CID_154699598 | CID_154699598 | |
| 0.071 | 0.058 | 0.071 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.044 | 0.032 | 0.044 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.017 | 0.006 | 0.017 | Antibiotic Tetracycline-like | |||
| 0.119 | 0.107 | 0.119 | Farnesoid X receptor antagonist | |||
| 0.037 | 0.025 | 0.037 | Glutamate (mGluR3) antagonist | |||
| 0.039 | 0.028 | 0.039 | CF transmembrane conductance regulator antagonist | |||
| 0.051 | 0.041 | 0.051 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.166 | 0.155 | 0.405 | Peptidyltransferase inhibitor | 0.405 0.006 CID_154699598 | CID_154699598 | |
| 0.047 | 0.036 | 0.047 | Sigma receptor antagonist | |||
| 0.085 | 0.075 | 0.094 | Glutamate release inhibitor | 0.094 0.052 CID_154699598 | CID_154699598 | |
| 0.027 | 0.017 | 0.027 | Leukotriene D4 antagonist | |||
| 0.066 | 0.056 | 0.066 | Secretase beta inhibitor | |||
| 0.042 | 0.032 | 0.042 | Heme oxygenase inhibitor | |||
| 0.029 | 0.019 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.027 | 0.017 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.042 | 0.033 | 0.042 | NMDA receptor subunit 3B antagonist | |||
| 0.035 | 0.026 | 0.035 | Glutamate (mGluR8) antagonist | |||
| 0.036 | 0.028 | 0.036 | Delayed rectifier potassium channel blocker | |||
| 0.057 | 0.048 | 0.057 | TRPA1 antagonist | |||
| 0.086 | 0.078 | 0.086 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.033 | 0.025 | 0.033 | Protein kinase C beta I inhibitor | 0.032 0.027 CID_154699598 | ||
| 0.056 | 0.049 | 0.059 | Carbonic anhydrase inhibitor | 0.059 0.046 CID_154699598 | CID_154699598 | |
| 0.027 | 0.02 | 0.027 | Leukotriene B4 receptor 1 antagonist | |||
| 0.044 | 0.038 | 0.044 | Glutamate (mGluR group I) agonist | |||
| 0.121 | 0.115 | 0.121 | Thiol protease inhibitor | |||
| 0.047 | 0.041 | 0.047 | NMDA 2A receptor antagonist | |||
| 0.022 | 0.017 | 0.022 | Prostaglandin F2 alpha agonist | |||
| 0.053 | 0.05 | 0.053 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.047 | 0.044 | 0.079 | Carbonic anhydrase IX inhibitor | 0.079 0.028 CID_154699598 | CID_154699598 | |
| 0.047 | 0.045 | 0.108 | Glucose-6-phosphate translocase inhibitor | 0.108 0.005 CID_154699598 | CID_154699598 | |
| 0.109 | 0.106 | 0.109 | Interleukin 1 antagonist | |||
| 0.066 | 0.063 | 0.066 | Alpha 2a adrenoreceptor antagonist | |||
| 0.03 | 0.028 | 0.03 | Fumarate hydratase inhibitor | |||
| 0.016 | 0.014 | 0.023 | Telomerase stimulant | 0.023 0.005 CID_154699598 | CID_154699598 | |
| 0.022 | 0.02 | 0.073 | Protein 30S ribosomal subunit inhibitor | 0.073 0.005 CID_154699598 | CID_154699598 | |
| 0.06 | 0.058 | 0.06 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.02 | 0.018 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.116 | 0.115 | 0.345 | Thrombolytic | 0.345 0.017 CID_154699598 | CID_154699598 | |
| 0.048 | 0.048 | 0.101 | Alpha-mannosidase inhibitor | 0.101 0.006 CID_154699598 | CID_154699598 | |
| 0.038 | 0.038 | 0.053 | Guanylate cyclase inhibitor | 0.053 0.018 CID_154699598 | CID_154699598 | |
| 0.02 | 0.021 | 0.024 | Dopamine D1 agonist | 0.024 0.014 CID_154699598 | CID_154699598 | |
| 0.007 | 0.019 | 0.011 | Purinergic P2Y2 agonist | 0.011 0.007 CID_154699598 | CID_154699598 | |
| 0.036 | 0.049 | 0.103 | Mannosidase inhibitor | 0.103 0.005 CID_154699598 | CID_154699598 | |
| 0.14 | 0.156 | 0.38 | Platelet antagonist | 0.38 0.031 CID_154699598 | CID_154699598 | |
| 0.074 | 0.094 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.016 CID_154699598 | CID_154699598 | |
| 0.028 | 0.048 | 0.088 | Antibiotic Aminoglycoside-like | 0.088 0.004 CID_154699598 | CID_154699598 | |
| 0.048 | 0.074 | 0.08 | Nitric oxide donor | 0.08 0.022 CID_154699598 | CID_154699598 | |
| 0.048 | 0.081 | 0.071 | Lipocortins synthesis agonist | 0.071 0.021 CID_154699598 | CID_154699598 | |
| 0.045 | 0.084 | 0.068 | Adenine nucleotide translocase inhibitor | 0.068 0.017 CID_154699598 | CID_154699598 | |
| 0.005 | 0.063 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 CID_154699598 | CID_154699598 | |
| 0.009 | 0.076 | 0.02 | Corticosteroid-like | 0.02 0.017 CID_154699598 | CID_154699598 | |
| 0.018 | 0.111 | 0.046 | Phosphorylase inhibitor | 0.046 0.032 CID_154699598 | CID_154699598 | |
| 0.024 | 0.126 | 0.051 | Microtubule stabilization | 0.051 0.027 CID_154699598 | CID_154699598 | |
| 0.022 | 0.126 | 0.121 | Protein 50S ribosomal subunit inhibitor | 0.121 0.009 CID_154699598 | CID_154699598 | |
| 0.102 | 0.206 | 0.288 | Hypolipemic | 0.288 0.053 CID_154699598 | CID_154699598 | |
| 0.002 | 0.11 | 0.014 | Antibiotic Macrolide-like | 0.014 0.01 CID_154699598 | CID_154699598 | |
| 0.033 | 0.142 | 0.054 | Factor III inhibitor | 0.054 0.025 CID_154699598 | CID_154699598 | |
| 0.047 | 0.184 | 0.083 | Falcipain 2 inhibitor | 0.083 0.066 CID_154699598 | CID_154699598 | |
| 0.152 | 0.292 | 0.426 | Interleukin 2 agonist | 0.426 0.021 CID_154699598 | CID_154699598 | |
| 0.048 | 0.189 | 0.085 | Falcipain inhibitor | 0.085 0.068 CID_154699598 | CID_154699598 | |
| 0.009 | 0.173 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_154699598 | CID_154699598 | |
| 0.02 | 0.186 | 0.397 | Selectin antagonist | 0.397 0.003 CID_154699598 | CID_154699598 | |
| 0.025 | 0.226 | 0.057 | DNA gyrase inhibitor | 0.057 0.053 CID_154699598 | CID_154699598 | |
| 0.048 | 0.253 | 0.144 | Transcription factor NF kappa B stimulant | 0.144 0.017 CID_154699598 | CID_154699598 | |
| 0.004 | 0.244 | 0.027 | Squalene synthetase inhibitor | 0.027 0.026 CID_154699598 | CID_154699598 | |
| 0.09 | 0.357 | 0.292 | Angiogenesis inhibitor | 0.292 0.097 CID_154699598 | CID_154699598 | |
| 0.029 | 0.49 | 0.251 | Cell adhesion inhibitor | 0.251 0.015 CID_154699598 | CID_154699598 | |
| 0.01 | 0.54 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.009 CID_154699598 | CID_154699598 | |
| 0.013 | 0.56 | 0.126 | Cell adhesion molecule inhibitor | 0.126 0.022 CID_154699598 | CID_154699598 | |
| 0.015 | 0.597 | 0.221 | Anticoagulant | 0.221 0.046 CID_154699598 | CID_154699598 | |
| 0.014 | 0.602 | 0.088 | Factor IXa inhibitor | 0.088 0.013 CID_154699598 | CID_154699598 | |
| 0.041 | 0.637 | 0.426 | Immunomodulator | 0.426 0.037 CID_154699598 | CID_154699598 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |